APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon Like Peptide 2 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glucagon Like Peptide 2 Receptor Market Outlook and Growth Opportunities 2026

19 December 2025195 pages

Choose your research edition.

Industry ResearchGlucagon Like Peptide 2 Receptor Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Like Peptide 2 Receptor Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Glucagon Like Peptide 2 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Like Peptide 2 Receptor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Like Peptide 2 Receptor Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Glucagon Like Peptide 2 Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glucagon Like Peptide 2 Receptor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glucagon Like Peptide 2 Receptor market include Takeda, Tasly Pharmaceutical Group Co Ltd, Hanmi Pharmaceuticals Co Ltd, Zealand Pharma AS and Naia Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucagon Like Peptide 2 Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucagon Like Peptide 2 Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucagon Like Peptide 2 Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucagon Like Peptide 2 Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucagon Like Peptide 2 Receptor Segment by Company

Takeda

Tasly Pharmaceutical Group Co Ltd

Hanmi Pharmaceuticals Co Ltd

Zealand Pharma AS

Naia Ltd

Glucagon Like Peptide 2 Receptor Segment by Type

FE-203799

GXG-8

HM-15910

Glepaglutide

Others

Glucagon Like Peptide 2 Receptor Segment by Application

Diabetes

Diarrhea

Obesity

Short Bowel Syndrome

Others

Glucagon Like Peptide 2 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Glucagon Like Peptide 2 Receptor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glucagon Like Peptide 2 Receptor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glucagon Like Peptide 2 Receptor significant trends, drivers, influence factors in global and regions.

6. To analyze Glucagon Like Peptide 2 Receptor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon Like Peptide 2 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon Like Peptide 2 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon Like Peptide 2 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucagon Like Peptide 2 Receptor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucagon Like Peptide 2 Receptor industry.

Chapter 3: Detailed analysis of Glucagon Like Peptide 2 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glucagon Like Peptide 2 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glucagon Like Peptide 2 Receptor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glucagon Like Peptide 2 Receptor Industry Trends Table 2. Glucagon Like Peptide 2 Receptor Industry Drivers Table 3. Glucagon Like Peptide 2 Receptor Industry Opportunities and Challenges Table 4. Glucagon Like Peptide 2 Receptor Industry Restraints Table 5. Global Glucagon Like Peptide 2 Receptor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glucagon Like Peptide 2 Receptor Revenue Share by Company (2021-2026) Table 7. Global Glucagon Like Peptide 2 Receptor Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Company (2021-2026) Table 9. Global Glucagon Like Peptide 2 Receptor Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Glucagon Like Peptide 2 Receptor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glucagon Like Peptide 2 Receptor Key Company Manufacturing Base & Headquarters Table 12. Global Glucagon Like Peptide 2 Receptor Company, Product Type & Application Table 13. Global Glucagon Like Peptide 2 Receptor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of FE-203799 Table 18. Significant Companies of GXG-8 Table 19. Significant Companies of HM-15910 Table 20. Significant Companies of Glepaglutide Table 21. Significant Companies of Others Table 22. Global Glucagon Like Peptide 2 Receptor Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Glucagon Like Peptide 2 Receptor Sales Volume by Type (2021-2026) & (W Units) Table 24. Global Glucagon Like Peptide 2 Receptor Sales Volume by Type (2027-2032) & (W Units) Table 25. Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Type (2021-2026) Table 26. Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Type (2027-2032) Table 27. Global Glucagon Like Peptide 2 Receptor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Glucagon Like Peptide 2 Receptor Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Glucagon Like Peptide 2 Receptor Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Type (2021-2026) Table 31. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Diabetes Table 33. Significant Companies of Diarrhea Table 34. Significant Companies of Obesity Table 35. Significant Companies of Short Bowel Syndrome Table 36. Significant Companies of Others Table 37. Global Glucagon Like Peptide 2 Receptor Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Glucagon Like Peptide 2 Receptor Sales Volume by Application (2021-2026) & (W Units) Table 39. Global Glucagon Like Peptide 2 Receptor Sales Volume by Application (2027-2032) & (W Units) Table 40. Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Application (2021-2026) Table 41. Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Application (2027-2032) Table 42. Global Glucagon Like Peptide 2 Receptor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Glucagon Like Peptide 2 Receptor Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Glucagon Like Peptide 2 Receptor Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Application (2021-2026) Table 46. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Application (2027-2032) Table 47. Global Glucagon Like Peptide 2 Receptor Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Glucagon Like Peptide 2 Receptor Sales by Region (2021-2026) & (W Units) Table 49. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2021-2026) Table 50. Global Glucagon Like Peptide 2 Receptor Sales by Region (2027-2032) & (W Units) Table 51. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2027-2032) Table 52. Global Glucagon Like Peptide 2 Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Glucagon Like Peptide 2 Receptor Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Region (2021-2026) Table 55. Global Glucagon Like Peptide 2 Receptor Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Region (2027-2032) Table 57. Global Glucagon Like Peptide 2 Receptor Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Glucagon Like Peptide 2 Receptor Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Glucagon Like Peptide 2 Receptor Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. Global Glucagon Like Peptide 2 Receptor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 62. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2026) Table 63. Global Glucagon Like Peptide 2 Receptor Sales by Country (2027-2032) & (W Units) Table 64. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2027-2032) Table 65. Global Glucagon Like Peptide 2 Receptor Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Glucagon Like Peptide 2 Receptor Sales Value Market Share by Country (2021-2026) Table 67. Global Glucagon Like Peptide 2 Receptor Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Glucagon Like Peptide 2 Receptor Sales Value Market Share by Country (2027-2032) Table 69. Takeda Company Information Table 70. Takeda Business Overview Table 71. Takeda Glucagon Like Peptide 2 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Takeda Glucagon Like Peptide 2 Receptor Product Portfolio Table 73. Takeda Recent Development Table 74. Tasly Pharmaceutical Group Co Ltd Company Information Table 75. Tasly Pharmaceutical Group Co Ltd Business Overview Table 76. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 78. Tasly Pharmaceutical Group Co Ltd Recent Development Table 79. Hanmi Pharmaceuticals Co Ltd Company Information Table 80. Hanmi Pharmaceuticals Co Ltd Business Overview Table 81. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 83. Hanmi Pharmaceuticals Co Ltd Recent Development Table 84. Zealand Pharma AS Company Information Table 85. Zealand Pharma AS Business Overview Table 86. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolio Table 88. Zealand Pharma AS Recent Development Table 89. Naia Ltd Company Information Table 90. Naia Ltd Business Overview Table 91. Naia Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 93. Naia Ltd Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Glucagon Like Peptide 2 Receptor Distributors List Table 97. Glucagon Like Peptide 2 Receptor Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Glucagon Like Peptide 2 Receptor Product Image Figure 2. Global Glucagon Like Peptide 2 Receptor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Like Peptide 2 Receptor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glucagon Like Peptide 2 Receptor Sales (2021-2032) & (W Units) Figure 5. Global Glucagon Like Peptide 2 Receptor Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Glucagon Like Peptide 2 Receptor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. FE-203799 Image Figure 10. GXG-8 Image Figure 11. HM-15910 Image Figure 12. Glepaglutide Image Figure 13. Others Image Figure 14. Global Glucagon Like Peptide 2 Receptor Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Glucagon Like Peptide 2 Receptor Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Type (2021-2032) Figure 17. Global Glucagon Like Peptide 2 Receptor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Glucagon Like Peptide 2 Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Type (2021-2032) Figure 20. Diabetes Image Figure 21. Diarrhea Image Figure 22. Obesity Image Figure 23. Short Bowel Syndrome Image Figure 24. Others Image Figure 25. Global Glucagon Like Peptide 2 Receptor Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Glucagon Like Peptide 2 Receptor Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Application (2021-2032) Figure 28. Global Glucagon Like Peptide 2 Receptor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Glucagon Like Peptide 2 Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Application (2021-2032) Figure 31. Global Glucagon Like Peptide 2 Receptor Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 32. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Glucagon Like Peptide 2 Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Glucagon Like Peptide 2 Receptor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Glucagon Like Peptide 2 Receptor Sales Value (2021-2032) & (US$ Million) Figure 36. North America Glucagon Like Peptide 2 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Glucagon Like Peptide 2 Receptor Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Glucagon Like Peptide 2 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Glucagon Like Peptide 2 Receptor Sales Value (2021-2032) & (US$ Million) Figure 42. South America Glucagon Like Peptide 2 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Glucagon Like Peptide 2 Receptor Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Glucagon Like Peptide 2 Receptor Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • FE-203799
  • GXG-8
  • HM-15910
  • Glepaglutide
  • Others
Applications
  • Diabetes
  • Diarrhea
  • Obesity
  • Short Bowel Syndrome
  • Others
Companies covered
  • Takeda
  • Tasly Pharmaceutical Group Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • Zealand Pharma AS
  • Naia Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucagon Like Peptide 2 Receptor Sales Value (2021-2032)
  4. 1.2.2 Global Glucagon Like Peptide 2 Receptor Sales Volume (2021-2032)
  5. 1.2.3 Global Glucagon Like Peptide 2 Receptor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glucagon Like Peptide 2 Receptor Market Dynamics
  1. 2.1 Glucagon Like Peptide 2 Receptor Industry Trends
  2. 2.2 Glucagon Like Peptide 2 Receptor Industry Drivers
  3. 2.3 Glucagon Like Peptide 2 Receptor Industry Opportunities and Challenges
  4. 2.4 Glucagon Like Peptide 2 Receptor Industry Restraints
3 Glucagon Like Peptide 2 Receptor Market by Company
  1. 3.1 Global Glucagon Like Peptide 2 Receptor Company Revenue Ranking in 2025
  2. 3.2 Global Glucagon Like Peptide 2 Receptor Revenue by Company (2021-2026)
  3. 3.3 Global Glucagon Like Peptide 2 Receptor Sales Volume by Company (2021-2026)
  4. 3.4 Global Glucagon Like Peptide 2 Receptor Average Price by Company (2021-2026)
  5. 3.5 Global Glucagon Like Peptide 2 Receptor Company Ranking (2024-2026)
  6. 3.6 Global Glucagon Like Peptide 2 Receptor Company Manufacturing Base and Headquarters
  7. 3.7 Global Glucagon Like Peptide 2 Receptor Company Product Type and Application
  8. 3.8 Global Glucagon Like Peptide 2 Receptor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glucagon Like Peptide 2 Receptor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glucagon Like Peptide 2 Receptor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glucagon Like Peptide 2 Receptor Market by Type
  1. 4.1 Glucagon Like Peptide 2 Receptor Type Introduction
  2. 4.1.1 FE-203799
  3. 4.1.2 GXG-8
  4. 4.1.3 HM-15910
  5. 4.1.4 Glepaglutide
  6. 4.1.5 Others
  7. 4.2 Global Glucagon Like Peptide 2 Receptor Sales Volume by Type
  8. 4.2.1 Global Glucagon Like Peptide 2 Receptor Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Glucagon Like Peptide 2 Receptor Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Glucagon Like Peptide 2 Receptor Sales Value by Type
  12. 4.3.1 Global Glucagon Like Peptide 2 Receptor Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Glucagon Like Peptide 2 Receptor Sales Value by Type (2021-2032)
  14. 4.3.3 Global Glucagon Like Peptide 2 Receptor Sales Value Share by Type (2021-2032)
5 Glucagon Like Peptide 2 Receptor Market by Application
  1. 5.1 Glucagon Like Peptide 2 Receptor Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Diarrhea
  4. 5.1.3 Obesity
  5. 5.1.4 Short Bowel Syndrome
  6. 5.1.5 Others
  7. 5.2 Global Glucagon Like Peptide 2 Receptor Sales Volume by Application
  8. 5.2.1 Global Glucagon Like Peptide 2 Receptor Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glucagon Like Peptide 2 Receptor Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Glucagon Like Peptide 2 Receptor Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Glucagon Like Peptide 2 Receptor Sales Value by Application
  12. 5.3.1 Global Glucagon Like Peptide 2 Receptor Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glucagon Like Peptide 2 Receptor Sales Value by Application (2021-2032)
  14. 5.3.3 Global Glucagon Like Peptide 2 Receptor Sales Value Share by Application (2021-2032)
6 Glucagon Like Peptide 2 Receptor Regional Sales and Value Analysis
  1. 6.1 Global Glucagon Like Peptide 2 Receptor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucagon Like Peptide 2 Receptor Sales by Region (2021-2032)
  3. 6.2.1 Global Glucagon Like Peptide 2 Receptor Sales by Region: 2021-2026
  4. 6.2.2 Global Glucagon Like Peptide 2 Receptor Sales by Region (2027-2032)
  5. 6.3 Global Glucagon Like Peptide 2 Receptor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glucagon Like Peptide 2 Receptor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glucagon Like Peptide 2 Receptor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glucagon Like Peptide 2 Receptor Sales Value by Region (2027-2032)
  9. 6.5 Global Glucagon Like Peptide 2 Receptor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glucagon Like Peptide 2 Receptor Sales Value (2021-2032)
  12. 6.6.2 North America Glucagon Like Peptide 2 Receptor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glucagon Like Peptide 2 Receptor Sales Value (2021-2032)
  15. 6.7.2 Europe Glucagon Like Peptide 2 Receptor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glucagon Like Peptide 2 Receptor Sales Value (2021-2032)
  21. 6.9.2 South America Glucagon Like Peptide 2 Receptor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Value Share by Country, 2025 VS 2032
7 Glucagon Like Peptide 2 Receptor Country-level Sales and Value Analysis
  1. 7.1 Global Glucagon Like Peptide 2 Receptor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glucagon Like Peptide 2 Receptor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glucagon Like Peptide 2 Receptor Sales by Country (2021-2032)
  4. 7.3.1 Global Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026)
  5. 7.3.2 Global Glucagon Like Peptide 2 Receptor Sales by Country (2027-2032)
  6. 7.4 Global Glucagon Like Peptide 2 Receptor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glucagon Like Peptide 2 Receptor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glucagon Like Peptide 2 Receptor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glucagon Like Peptide 2 Receptor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glucagon Like Peptide 2 Receptor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glucagon Like Peptide 2 Receptor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Glucagon Like Peptide 2 Receptor Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Tasly Pharmaceutical Group Co Ltd
  8. 8.2.1 Tasly Pharmaceutical Group Co Ltd Company Information
  9. 8.2.2 Tasly Pharmaceutical Group Co Ltd Business Overview
  10. 8.2.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  12. 8.2.5 Tasly Pharmaceutical Group Co Ltd Recent Developments
  13. 8.3 Hanmi Pharmaceuticals Co Ltd
  14. 8.3.1 Hanmi Pharmaceuticals Co Ltd Company Information
  15. 8.3.2 Hanmi Pharmaceuticals Co Ltd Business Overview
  16. 8.3.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  18. 8.3.5 Hanmi Pharmaceuticals Co Ltd Recent Developments
  19. 8.4 Zealand Pharma AS
  20. 8.4.1 Zealand Pharma AS Company Information
  21. 8.4.2 Zealand Pharma AS Business Overview
  22. 8.4.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolio
  24. 8.4.5 Zealand Pharma AS Recent Developments
  25. 8.5 Naia Ltd
  26. 8.5.1 Naia Ltd Company Information
  27. 8.5.2 Naia Ltd Business Overview
  28. 8.5.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  30. 8.5.5 Naia Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucagon Like Peptide 2 Receptor Value Chain Analysis
  2. 9.1.1 Glucagon Like Peptide 2 Receptor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucagon Like Peptide 2 Receptor Sales Mode & Process
  6. 9.2 Glucagon Like Peptide 2 Receptor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucagon Like Peptide 2 Receptor Distributors
  9. 9.2.3 Glucagon Like Peptide 2 Receptor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst